TcL Pharma strengthens its team with the appointments of Dr Didier Hoch to the Board of Directors, and of Operations Director Dr Jean-Hugues Masgnaux who joins the Management Committee

01-Apr-2011 - France

TcL Pharma announced the appointment of Dr Didier Hoch to the Board of Directors and of Dr Jean-Hugues Masgnaux as Operations Director.

Didier Hoch is a doctor with 25 years’ experience in the pharmaceutical industry and in vaccines. Between 2000 and 2010 he ran Sanofi Pasteur MSD (a European joint venture vaccine between Sanofi Aventis & Merck), where he led the launch of Gardasil. Prior to this, he carried out various management functions such as Product Manager, Marketing Director, Deputy General Manager and Vice-President Africa & Middle-East at Rhône Poulenc Rorer (1985-2000), then he joined from 2000 to 2010 Aventis (Europe, Middle-East/African regions). Didier was also President (2003/2009) of the European Vaccines Manufacturers Association EVM, and since 2006 has presided over the French Pharmaceutical Companies Association LEEM as well as the French Labour Union MEDEF’s Health & Life Sciences Committee since 2009.

Jean-Hugues Masgnaux is a doctor and business school graduate with considerable marketing expertise in the domain of medical treatments, sales and development. He has worked in organisations of various sizes both in France and abroad on pharmaceutical and biotechnological business projects. Jean-Hugues began his career as an independent business development consultant at Innothera Laboratories & CNI, going on to become manager of Licences & Agreements at Servier Group and Product Manager for Fournier Group. Between 1996 and 2000 he progressed from the position of senior Product Manager to Regional Sales director and then Marketing Manager at Bayer Pharma. Between 2005 and 2005 he was Infectiology Marketing Manager for the France subsidiary of the Grünenthal group, then International Project Manager and Marketing Director for the French subsidiary. In 2005 he took on the role of President of Madaus Laboratories France, becoming President of the Rottapharm /
Madaus Group. In July 2009, Jean-Hugues set up ‘M&M Conseil’ (M&M Consulting) and among other activities works as Health Expert for Capgemini Consulting.

https://www.bionity.com/en/news/131676/tcl-pharma-strengthens-its-team-with-the-appointments-of-dr-didier-hoch-to-the-board-of-directors-and-of-operations-director-dr-jean-hugues-masgnaux-who-joins-the-management-committee.html